| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 10 | 2022 | 1623 | 1.640 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 3 | 2023 | 98 | 1.560 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2018 | 71 | 1.470 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2023 | 507 | 1.420 |
Why?
|
| RNA Helicases | 2 | 2022 | 69 | 1.410 |
Why?
|
| Receptors, Androgen | 4 | 2023 | 433 | 1.240 |
Why?
|
| Inflammation | 5 | 2022 | 1590 | 1.030 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2018 | 141 | 1.020 |
Why?
|
| Prostate | 6 | 2014 | 448 | 0.950 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2023 | 212 | 0.950 |
Why?
|
| Neoplasms | 5 | 2023 | 3027 | 0.940 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2023 | 18 | 0.840 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 351 | 0.840 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2022 | 12 | 0.790 |
Why?
|
| Guanidines | 1 | 2022 | 26 | 0.790 |
Why?
|
| GATA2 Transcription Factor | 1 | 2022 | 39 | 0.790 |
Why?
|
| Keto Acids | 1 | 2022 | 56 | 0.780 |
Why?
|
| Transaminases | 1 | 2022 | 36 | 0.780 |
Why?
|
| Stromal Cells | 6 | 2014 | 313 | 0.750 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 25 | 0.740 |
Why?
|
| Co-Repressor Proteins | 1 | 2021 | 39 | 0.730 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 320 | 0.680 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2023 | 2120 | 0.660 |
Why?
|
| Transforming Growth Factor beta | 4 | 2014 | 486 | 0.650 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 388 | 0.650 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 324 | 0.620 |
Why?
|
| Gene Transfer Techniques | 2 | 2018 | 365 | 0.620 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 267 | 0.590 |
Why?
|
| Alpharetrovirus | 1 | 2018 | 5 | 0.580 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 138 | 0.560 |
Why?
|
| Retroviridae | 1 | 2017 | 198 | 0.520 |
Why?
|
| Cell Line, Tumor | 9 | 2023 | 3752 | 0.510 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2014 | 106 | 0.510 |
Why?
|
| Mice | 18 | 2022 | 18911 | 0.490 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 1814 | 0.420 |
Why?
|
| Animals | 21 | 2022 | 36387 | 0.390 |
Why?
|
| Mice, SCID | 2 | 2022 | 613 | 0.330 |
Why?
|
| Signal Transduction | 5 | 2023 | 4897 | 0.320 |
Why?
|
| Androgens | 3 | 2023 | 292 | 0.310 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2017 | 644 | 0.300 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 2763 | 0.290 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2022 | 262 | 0.280 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2007 | 55 | 0.280 |
Why?
|
| Proteins | 4 | 2014 | 1087 | 0.250 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 60 | 0.240 |
Why?
|
| Androgen Antagonists | 2 | 2023 | 131 | 0.240 |
Why?
|
| Carcinoma | 1 | 2007 | 322 | 0.230 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 295 | 0.220 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 21 | 0.200 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 747 | 0.190 |
Why?
|
| Humans | 21 | 2023 | 133950 | 0.190 |
Why?
|
| Micrococcal Nuclease | 1 | 2001 | 7 | 0.190 |
Why?
|
| Staphylococcus | 1 | 2001 | 68 | 0.180 |
Why?
|
| Protein Isoforms | 1 | 2022 | 429 | 0.180 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 148 | 0.180 |
Why?
|
| Cell Line | 4 | 2021 | 2836 | 0.180 |
Why?
|
| Mice, Knockout | 3 | 2021 | 3981 | 0.180 |
Why?
|
| Protein Conformation | 3 | 2003 | 870 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 1102 | 0.170 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 137 | 0.170 |
Why?
|
| Th1 Cells | 1 | 2021 | 159 | 0.170 |
Why?
|
| Th17 Cells | 1 | 2021 | 101 | 0.170 |
Why?
|
| Kupffer Cells | 1 | 2020 | 22 | 0.170 |
Why?
|
| Mass Spectrometry | 1 | 2001 | 371 | 0.160 |
Why?
|
| Cell Survival | 1 | 2022 | 889 | 0.160 |
Why?
|
| Mice, Nude | 5 | 2014 | 777 | 0.160 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 74 | 0.160 |
Why?
|
| Hepatitis | 1 | 2020 | 58 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 703 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2022 | 1006 | 0.160 |
Why?
|
| Male | 15 | 2023 | 65909 | 0.160 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 525 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 455 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 4823 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 247 | 0.150 |
Why?
|
| Serine Endopeptidases | 2 | 2014 | 204 | 0.150 |
Why?
|
| DNA Damage | 1 | 2021 | 545 | 0.150 |
Why?
|
| HEK293 Cells | 1 | 2021 | 813 | 0.150 |
Why?
|
| DNA Repair | 1 | 2021 | 629 | 0.140 |
Why?
|
| Luciferases | 1 | 1997 | 137 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 4 | 2007 | 263 | 0.140 |
Why?
|
| Transplantation, Heterologous | 3 | 2007 | 275 | 0.140 |
Why?
|
| Calcium | 1 | 2022 | 1145 | 0.140 |
Why?
|
| Oncogenes | 1 | 2018 | 179 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2014 | 139 | 0.130 |
Why?
|
| Ribosomes | 1 | 1997 | 139 | 0.130 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 4778 | 0.130 |
Why?
|
| Mitochondria | 1 | 2022 | 744 | 0.130 |
Why?
|
| Cysteine Endopeptidases | 1 | 2017 | 119 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2017 | 118 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 248 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2021 | 749 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2014 | 9 | 0.120 |
Why?
|
| Pteridines | 1 | 2014 | 12 | 0.120 |
Why?
|
| Phenylthiohydantoin | 1 | 2014 | 15 | 0.120 |
Why?
|
| Sequence Deletion | 1 | 2017 | 537 | 0.120 |
Why?
|
| Kallikreins | 1 | 2014 | 31 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2020 | 686 | 0.110 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 40 | 0.110 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 426 | 0.110 |
Why?
|
| Myofibroblasts | 1 | 2014 | 79 | 0.110 |
Why?
|
| Benzamides | 1 | 2014 | 125 | 0.110 |
Why?
|
| Nitriles | 1 | 2014 | 155 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2014 | 238 | 0.110 |
Why?
|
| Disease Progression | 2 | 2013 | 2243 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 1 | 2014 | 272 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 2526 | 0.100 |
Why?
|
| beta Catenin | 1 | 2015 | 229 | 0.100 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 153 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2014 | 450 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 542 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 1134 | 0.100 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 484 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 392 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2015 | 363 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 1326 | 0.090 |
Why?
|
| Apoptosis | 2 | 2017 | 1929 | 0.090 |
Why?
|
| Ganglia | 1 | 2010 | 20 | 0.090 |
Why?
|
| Wound Healing | 1 | 2014 | 495 | 0.090 |
Why?
|
| Macrophages | 1 | 2014 | 704 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2014 | 2899 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2013 | 1596 | 0.080 |
Why?
|
| 3T3 Cells | 2 | 2005 | 123 | 0.070 |
Why?
|
| Female | 3 | 2022 | 71696 | 0.070 |
Why?
|
| Protein Biosynthesis | 2 | 2003 | 675 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 149 | 0.070 |
Why?
|
| Liver | 1 | 2015 | 1876 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2014 | 2548 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 1788 | 0.060 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 691 | 0.060 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2005 | 22 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 506 | 0.060 |
Why?
|
| HIV-1 | 1 | 2007 | 487 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2003 | 67 | 0.050 |
Why?
|
| Muramidase | 1 | 2003 | 99 | 0.050 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2023 | 18 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1298 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2023 | 183 | 0.050 |
Why?
|
| Binding Sites | 2 | 2003 | 1370 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 70 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2003 | 1132 | 0.050 |
Why?
|
| Radioimmunotherapy | 1 | 2021 | 2 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2001 | 164 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 253 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 1628 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 1761 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 68 | 0.040 |
Why?
|
| Ligands | 1 | 2001 | 572 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2021 | 182 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 781 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 177 | 0.040 |
Why?
|
| Cell Division | 2 | 2014 | 774 | 0.040 |
Why?
|
| Coleoptera | 1 | 1997 | 15 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1997 | 327 | 0.030 |
Why?
|
| Protein Binding | 1 | 2001 | 1832 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 1069 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 172 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 204 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 317 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 1997 | 412 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 911 | 0.030 |
Why?
|
| Cell Movement | 2 | 2014 | 916 | 0.030 |
Why?
|
| Osteopontin | 1 | 2014 | 51 | 0.030 |
Why?
|
| Fibronectins | 1 | 2014 | 112 | 0.030 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2014 | 63 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 246 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 141 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 1438 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 363 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2015 | 201 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 273 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2014 | 369 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 714 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1997 | 1001 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 1755 | 0.020 |
Why?
|
| Organoids | 1 | 2014 | 298 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4551 | 0.020 |
Why?
|
| Time Factors | 1 | 2001 | 6587 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1997 | 1620 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 791 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 716 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 669 | 0.020 |
Why?
|
| Obesity | 1 | 2020 | 2411 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1918 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 1070 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2007 | 247 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2014 | 2025 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 215 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 3170 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 1000 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 13011 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 1411 | 0.010 |
Why?
|
| CHO Cells | 1 | 2003 | 166 | 0.010 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2003 | 25 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2003 | 87 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2003 | 52 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 283 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 398 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2003 | 399 | 0.010 |
Why?
|
| Chickens | 1 | 2003 | 640 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2003 | 174 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2003 | 386 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 243 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2002 | 155 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 3169 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 382 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 6292 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 9888 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2002 | 833 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3967 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 31958 | 0.010 |
Why?
|